1. Home
  2. KLTO
  3. KLTO Forecast

as 04-24-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

NYSE

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

More About Our KLTO ML Model...

What kind of parameters do you use to train KLTO stocks ML model?

To train our stocks KLTO ML model, we use historical data with over 25 parameters, including volume indicators, volatility indicators, momentum indicators, trend indicators, and other metrics.

How often do you update KLTO ML model?

We update our ML model either weekly or biweekly, depending on the market capitalization of the stocks, using TensorFlow, typically over the weekend.

Why is the accuracy of your KLTO model low?

Unfortunately, our current data provider offers limited historical data, which impacts the accuracy of our ML model. However, as we continue to gather more data over time and add more indicators, we expect the accuracy of our model to improve.

How can I provide and share more data with you to increase your ML model accuracy?

We would greatly appreciate your contribution. Please send an email to [email protected]

Do you offer an ML model for shorter time periods, such as 5 minutes or 15 minutes?

Yes, we offer it for strategy purposes only, with intervals: 1 minute, 2 minutes, 5 minutes, 15 minutes, and 30 minutes etc.

Can I rely on your ML model to make financial decisions regarding buying or selling stocks, or is it only intended for learning purposes?

Our ML model is primarily designed for educational purposes and is not intended to provide financial advice. We strongly recommend consulting with a financial advisor before making any buying or selling decisions.

Share on Social Networks: